These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12498965)
1. Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice. Kurosaki R; Akasaka M; Michimata M; Matsubara M; Imai Y; Araki T Neurobiol Aging; 2003; 24(2):315-9. PubMed ID: 12498965 [TBL] [Abstract][Full Text] [Related]
2. Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures. Antkiewicz-Michaluk L; Romańska I; Vetulani J Psychopharmacology (Berl); 1996 Nov; 128(1):39-44. PubMed ID: 8944404 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibitors cause motor deficits in mice. Araki T; Mizutani H; Matsubara M; Imai Y; Mizugaki M; Itoyama Y Eur Neuropsychopharmacol; 2001 Apr; 11(2):125-33. PubMed ID: 11313158 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Commissiong JW; Slimovitch C; Toffano G Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171 [TBL] [Abstract][Full Text] [Related]
5. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
6. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL; Kilpatrick IC Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647 [TBL] [Abstract][Full Text] [Related]
7. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats. Kelly E; Jenner P; Marsden CD J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284 [TBL] [Abstract][Full Text] [Related]
8. Increased striatal dopamine turnover following acute administration of rotenone to mice. Thiffault C; Langston JW; Di Monte DA Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582 [TBL] [Abstract][Full Text] [Related]
9. Effects of the anti-dementia drug hopantenate calcium upon striatal dopaminergic neurons in young and aged rats. Toide K Arch Int Pharmacodyn Ther; 1989; 299():7-13. PubMed ID: 2570556 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic mediation of beta-endorphin-induced catalepsy. Van Loon GR; Kim C Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367 [TBL] [Abstract][Full Text] [Related]
11. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Robinson TE; Yew J; Paulson PE; Camp DM Neurosci Lett; 1990 Mar; 110(1-2):193-8. PubMed ID: 1691471 [TBL] [Abstract][Full Text] [Related]
12. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Schumm S; Sebban C; Cohen-Salmon C; Callebert J; Launay JM; Golmard JL; Boussicault L; Petropoulos I; Hild A; Rousselet E; Prigent A; Friguet B; Mariani J; Hirsch EC J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926 [TBL] [Abstract][Full Text] [Related]
13. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis. Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456 [TBL] [Abstract][Full Text] [Related]
14. Dual effects of nicotine on neuroleptic-induced changes of striatal dopamine metabolism in mice. Haikala H Pharmacol Toxicol; 1989 Apr; 64(4):334-9. PubMed ID: 2568630 [TBL] [Abstract][Full Text] [Related]
15. L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice. Cooper DR; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden CD J Pharm Pharmacol; 1987 Oct; 39(10):809-18. PubMed ID: 2891818 [TBL] [Abstract][Full Text] [Related]
16. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056 [TBL] [Abstract][Full Text] [Related]
17. [Age-related changes in the dopaminergic system in rat striatum]. Budygin EA; Kovalev GI; Gaĭntdinov RR; Kudrin VS; Voronina TA Biull Eksp Biol Med; 1993 Mar; 115(3):301-3. PubMed ID: 8054633 [TBL] [Abstract][Full Text] [Related]
18. Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia. Imam SZ; Ali SF J Neurochem; 2001 Sep; 78(5):952-9. PubMed ID: 11553669 [TBL] [Abstract][Full Text] [Related]
19. Age influences abnormalities in striatal dopamine metabolism during and after transient forebrain ischemia. Ding A; Németh G; Hoyer S J Neural Transm Park Dis Dement Sect; 1992; 4(3):213-25. PubMed ID: 1627255 [TBL] [Abstract][Full Text] [Related]
20. Dopamine in the basal ganglia and benzodiazepine-induced sedation. Brose N; O'Neill RD; Boutelle MG; Fillenz M Neuropharmacology; 1988 Jun; 27(6):589-95. PubMed ID: 3419542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]